A recent phase III randomized trial has failed to demonstrate an improvement in disease-free survival with the addition of irinotecan to 5-fluorouracil and folinic acid as adjuvant treatment for ...
For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin ...
THURSDAY, Jan. 23, 2025 (HealthDay News) -- For patients with resectable esophageal adenocarcinoma, perioperative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results